Shopping Cart 0
Cart Subtotal
AED 0

Quanterix Corp (QTRX) - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 8258

Details

Summary

Quanterix Corp (Quanterix) is a life sciences company that develops and markets ultra-sensitive digital immunoassay platform that improves precision health for life sciences research and diagnostics. It develops platform based on its proprietary digital single molecule array, Simoa detection technology that allows the detection of proteins and nucleic acids in biological samples. Quanterix's kits include components required to run tests, such as capture and detector reagents, beads, enzyme reagents and enzyme substrates. Its consumables include Simoa disks, cuvettes and disposable tips. Its technology is used for research applications in various therapeutic areas, including neurology, cardiology, oncology, inflammation and infectious diseases. The company's Simoa technology serves life science research, diagnostics and precision health screening markets. It also provides contract research services. Quanterix is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Quanterix Corp

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Quanterix Corp Company Overview

Quanterix Corp Company Snapshot

Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview

Quanterix Corp-Pipeline Analysis Overview

Quanterix Corp-Key Facts

Quanterix Corp-Major Products and Services

Quanterix Corp Pipeline Products by Development Stage

Quanterix Corp Pipeline Products Overview

AccuPSA Test

AccuPSA Test Product Overview

Antigen Detection Assay-Tuberculosis

Antigen Detection Assay-Tuberculosis Product Overview

Diagnostic Blood Test-Huntington's Disease

Diagnostic Blood Test-Huntington's Disease Product Overview

Digital ELISA-Crohn's Disease

Digital ELISA-Crohn's Disease Product Overview

Digital ELISA Assay-C. Difficile

Digital ELISA Assay-C. Difficile Product Overview

NeuroFilament Light Assay-Alzheimer's Disease

NeuroFilament Light Assay-Alzheimer's Disease Product Overview

POC Device-Neurological Injuries

POC Device-Neurological Injuries Product Overview

Simoa 3.0

Simoa 3.0 Product Overview

Simoa 4.0

Simoa 4.0 Product Overview

Simoa 5.0

Simoa 5.0 Product Overview

SiMoA HD-1 Analyzer-Botulinum Toxin Assay

SiMoA HD-1 Analyzer-Botulinum Toxin Assay Product Overview

Simoa HD-1 Analyzer-Lung Cancer

Simoa HD-1 Analyzer-Lung Cancer Product Overview

Simoa HD-1 Analyzer-Pancreatic Cancer

Simoa HD-1 Analyzer-Pancreatic Cancer Product Overview

SiMoA HD-1 Analyzer-Prostate Cancer Assay

SiMoA HD-1 Analyzer-Prostate Cancer Assay Product Overview

Quanterix Corp-Key Competitors

Quanterix Corp-Key Employees

Quanterix Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Quanterix Corp, Recent Developments

Nov 06, 2019: Quanterix releases operating results for third quarter 2019

Oct 03, 2019: Quanterix announces recipients of annual accelerator grant program

Sep 16, 2019: Quanterix Serum Nf-L Assay powers key trial and study results presented at ECTRIMS 2019

Sep 11, 2019: Quanterix Simoa technology powers Multiple Sclerosis research with more than 50 presentations at ECTRIMS 2019

Aug 06, 2019: Quanterix releases operating results for second quarter 2019

Jul 26, 2019: Sarah Hlavinka elected to Quanterix board of directors

Jun 04, 2019: Quanterix raises USD 49.7 million and announces introduction of latest model Simoa HD-X Analyzer at BIO 2019 International Convention

May 29, 2019: Quanterix expands headquarters to new, state-of-the-art facility in Billerica, Mass. as demand continues to grow for its disruptive Simoa platforms

May 09, 2019: Quanterix releases operating results for first quarter 2019

May 06, 2019: Quanterix' Simoa Technology powers more than 85 percent of neurofilament light biomarker research to be unveiled at American Academy of Neurology Annual Meeting

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Quanterix Corp Pipeline Products by Equipment Type

Quanterix Corp Pipeline Products by Development Stage


List Of Table

List of Tables

Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview

Quanterix Corp Pipeline Products by Equipment Type

Quanterix Corp Pipeline Products by Indication

Quanterix Corp, Key Facts

Quanterix Corp, Major Products and Services

Quanterix Corp Number of Pipeline Products by Development Stage

Quanterix Corp Pipeline Products Summary by Development Stage

AccuPSA Test-Product Status

AccuPSA Test-Product Description

Antigen Detection Assay-Tuberculosis-Product Status

Antigen Detection Assay-Tuberculosis-Product Description

Diagnostic Blood Test-Huntington's Disease-Product Status

Diagnostic Blood Test-Huntington's Disease-Product Description

Digital ELISA-Crohn's Disease-Product Status

Digital ELISA-Crohn's Disease-Product Description

Digital ELISA Assay-C. Difficile-Product Status

Digital ELISA Assay-C. Difficile-Product Description

NeuroFilament Light Assay-Alzheimer's Disease-Product Status

NeuroFilament Light Assay-Alzheimer's Disease-Product Description

POC Device-Neurological Injuries-Product Status

POC Device-Neurological Injuries-Product Description

Simoa 3.0-Product Status

Simoa 3.0-Product Description

Simoa 4.0-Product Status

Simoa 4.0-Product Description

Simoa 5.0-Product Status

Simoa 5.0-Product Description

SiMoA HD-1 Analyzer-Botulinum Toxin Assay-Product Status

SiMoA HD-1 Analyzer-Botulinum Toxin Assay-Product Description

Simoa HD-1 Analyzer-Lung Cancer-Product Status

Simoa HD-1 Analyzer-Lung Cancer-Product Description

Simoa HD-1 Analyzer-Pancreatic Cancer-Product Status

Simoa HD-1 Analyzer-Pancreatic Cancer-Product Description

SiMoA HD-1 Analyzer-Prostate Cancer Assay-Product Status

SiMoA HD-1 Analyzer-Prostate Cancer Assay-Product Description

Quanterix Corp, Key Employees

Quanterix Corp, Subsidiaries

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Quanterix Corp, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Ortho-Clinical Diagnostics Inc

Luminex Corp

Bio Techne Corp

Company Profile

Company Profile Title

Summary

Quanterix Corp (Quanterix) is a life sciences company that develops and markets ultra-sensitive digital immunoassay platform that improves precision health for life sciences research and diagnostics. It develops platform based on its proprietary digital single molecule array, Simoa detection technology that allows the detection of proteins and nucleic acids in biological samples. Quanterix's kits include components required to run tests, such as capture and detector reagents, beads, enzyme reagents and enzyme substrates. Its consumables include Simoa disks, cuvettes and disposable tips. Its technology is used for research applications in various therapeutic areas, including neurology, cardiology, oncology, inflammation and infectious diseases. The company's Simoa technology serves life science research, diagnostics and precision health screening markets. It also provides contract research services. Quanterix is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Quanterix Corp

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Quanterix Corp Company Overview

Quanterix Corp Company Snapshot

Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview

Quanterix Corp-Pipeline Analysis Overview

Quanterix Corp-Key Facts

Quanterix Corp-Major Products and Services

Quanterix Corp Pipeline Products by Development Stage

Quanterix Corp Pipeline Products Overview

AccuPSA Test

AccuPSA Test Product Overview

Antigen Detection Assay-Tuberculosis

Antigen Detection Assay-Tuberculosis Product Overview

Diagnostic Blood Test-Huntington's Disease

Diagnostic Blood Test-Huntington's Disease Product Overview

Digital ELISA-Crohn's Disease

Digital ELISA-Crohn's Disease Product Overview

Digital ELISA Assay-C. Difficile

Digital ELISA Assay-C. Difficile Product Overview

NeuroFilament Light Assay-Alzheimer's Disease

NeuroFilament Light Assay-Alzheimer's Disease Product Overview

POC Device-Neurological Injuries

POC Device-Neurological Injuries Product Overview

Simoa 3.0

Simoa 3.0 Product Overview

Simoa 4.0

Simoa 4.0 Product Overview

Simoa 5.0

Simoa 5.0 Product Overview

SiMoA HD-1 Analyzer-Botulinum Toxin Assay

SiMoA HD-1 Analyzer-Botulinum Toxin Assay Product Overview

Simoa HD-1 Analyzer-Lung Cancer

Simoa HD-1 Analyzer-Lung Cancer Product Overview

Simoa HD-1 Analyzer-Pancreatic Cancer

Simoa HD-1 Analyzer-Pancreatic Cancer Product Overview

SiMoA HD-1 Analyzer-Prostate Cancer Assay

SiMoA HD-1 Analyzer-Prostate Cancer Assay Product Overview

Quanterix Corp-Key Competitors

Quanterix Corp-Key Employees

Quanterix Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Quanterix Corp, Recent Developments

Nov 06, 2019: Quanterix releases operating results for third quarter 2019

Oct 03, 2019: Quanterix announces recipients of annual accelerator grant program

Sep 16, 2019: Quanterix Serum Nf-L Assay powers key trial and study results presented at ECTRIMS 2019

Sep 11, 2019: Quanterix Simoa technology powers Multiple Sclerosis research with more than 50 presentations at ECTRIMS 2019

Aug 06, 2019: Quanterix releases operating results for second quarter 2019

Jul 26, 2019: Sarah Hlavinka elected to Quanterix board of directors

Jun 04, 2019: Quanterix raises USD 49.7 million and announces introduction of latest model Simoa HD-X Analyzer at BIO 2019 International Convention

May 29, 2019: Quanterix expands headquarters to new, state-of-the-art facility in Billerica, Mass. as demand continues to grow for its disruptive Simoa platforms

May 09, 2019: Quanterix releases operating results for first quarter 2019

May 06, 2019: Quanterix' Simoa Technology powers more than 85 percent of neurofilament light biomarker research to be unveiled at American Academy of Neurology Annual Meeting

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Quanterix Corp Pipeline Products by Equipment Type

Quanterix Corp Pipeline Products by Development Stage


List Of Table

List of Tables

Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview

Quanterix Corp Pipeline Products by Equipment Type

Quanterix Corp Pipeline Products by Indication

Quanterix Corp, Key Facts

Quanterix Corp, Major Products and Services

Quanterix Corp Number of Pipeline Products by Development Stage

Quanterix Corp Pipeline Products Summary by Development Stage

AccuPSA Test-Product Status

AccuPSA Test-Product Description

Antigen Detection Assay-Tuberculosis-Product Status

Antigen Detection Assay-Tuberculosis-Product Description

Diagnostic Blood Test-Huntington's Disease-Product Status

Diagnostic Blood Test-Huntington's Disease-Product Description

Digital ELISA-Crohn's Disease-Product Status

Digital ELISA-Crohn's Disease-Product Description

Digital ELISA Assay-C. Difficile-Product Status

Digital ELISA Assay-C. Difficile-Product Description

NeuroFilament Light Assay-Alzheimer's Disease-Product Status

NeuroFilament Light Assay-Alzheimer's Disease-Product Description

POC Device-Neurological Injuries-Product Status

POC Device-Neurological Injuries-Product Description

Simoa 3.0-Product Status

Simoa 3.0-Product Description

Simoa 4.0-Product Status

Simoa 4.0-Product Description

Simoa 5.0-Product Status

Simoa 5.0-Product Description

SiMoA HD-1 Analyzer-Botulinum Toxin Assay-Product Status

SiMoA HD-1 Analyzer-Botulinum Toxin Assay-Product Description

Simoa HD-1 Analyzer-Lung Cancer-Product Status

Simoa HD-1 Analyzer-Lung Cancer-Product Description

Simoa HD-1 Analyzer-Pancreatic Cancer-Product Status

Simoa HD-1 Analyzer-Pancreatic Cancer-Product Description

SiMoA HD-1 Analyzer-Prostate Cancer Assay-Product Status

SiMoA HD-1 Analyzer-Prostate Cancer Assay-Product Description

Quanterix Corp, Key Employees

Quanterix Corp, Subsidiaries

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Quanterix Corp, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Ortho-Clinical Diagnostics Inc

Luminex Corp

Bio Techne Corp